Samil Pharm (000520) — Free Cash Flow Generation Index
Samil Pharm (000520) has a Free Cash Flow Generation Index of -0.33x as of June 2025. Free cash flow of ₩-814.57 Million represents 0% of operating cash flow (₩2.44 Billion). Explore Samil Pharm capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Samil Pharm Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Samil Pharm across 10 annual periods. For the full cash flow conversion analysis, see Samil Pharm (000520) cash conversion ratio.
Annual Free Cash Flow Generation for Samil Pharm (2012–2024)
Year-by-year Free Cash Flow Generation Index for Samil Pharm. Check cash flow reinvestment rate of Samil Pharm to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.17x | ₩-3.02 Billion | ₩2.59 Billion | ₩5.61 Billion | ▼ -8.4% |
| 2023 | -1.08x | ₩-12.65 Billion | ₩11.75 Billion | ₩24.39 Billion | ▲ +90.0% |
| 2022 | -10.71x | ₩-44.50 Billion | ₩4.15 Billion | ₩48.48 Billion | ▲ +52.1% |
| 2021 | -22.35x | ₩-31.67 Billion | ₩1.42 Billion | ₩32.83 Billion | ▼ -1741.9% |
| 2020 | -1.21x | ₩-9.44 Billion | ₩7.77 Billion | ₩17.02 Billion | ▼ -230.4% |
| 2019 | -0.37x | ₩-3.89 Billion | ₩10.59 Billion | ₩13.89 Billion | ▲ +96.5% |
| 2017 | -10.43x | ₩-39.55 Billion | ₩3.79 Billion | ₩36.33 Billion | ▼ -682.6% |
| 2016 | 1.79x | ₩10.09 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -0.9% |
| 2015 | 1.81x | ₩5.28 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +31.0% |
| 2012 | 1.38x | ₩6.93 Billion | ₩5.02 Billion | ₩1.91 Billion | — |